Back to Search
NABIL MALEK, DO
DO
Internal Medicine Physician
NPI: 1104891514Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
PMID 19190348·Cancer Res·2009
7-preclinical
[Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC].
PMID 19156592·Z Gastroenterol·2009
6-review
Removal of Cr(VI) and As(V) from aqueous solutions by HDTMA-modified zeolite Y.
PMID 18632204·J Hazard Mater·2009
8-other
Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage.
PMID 19642171·Hepatology·2009
7-preclinical
Molecular therapy for the treatment of hepatocellular carcinoma.
PMID 19018262·Br J Cancer·2009
6-review
p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.
PMID 19443444·Nucleic Acids Res·2009
7-preclinical
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1.
PMID 19369968·Gene Ther·2009
7-preclinical
Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells.
PMID 18497084·Adv Exp Med Biol·2008
8-other
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
PMID 18598941·Cancer Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 975 E. THIRD STREET
CHATTANOOGA, TN 37403 - Phone
- (423) 266-1490
Quick Facts
- NPI
- 1104891514
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile